Pulmonary exacerbations

Show results for

Unknown (2430)
Transcriptomics (119)
Genomics (70)
Proteomics (13)
Metabolomics (6)
Genomic (1)
Methylation profiling (1)
Other (1)

Organisms

Homo sapiens (62)
Mus musculus (34)
Andropogon gerardi (6)
Bacteria (6)
Schizosaccharomyces pombe (4)
Pseudomonas aeruginosa (3)
Escherichia coli (2)
Danio rerio (2)
human lung metagenome (2)
Viruses (2)
Staphylococcus aureus (2)
Moraxella catarrhalis RH4 (1)
Metallosphaera sedula (1)
Bacteroides thetaiotaomicron (1)
Bombyx mori (1)
Toxoplasma gondii (1)
Nicotiana benthamiana (1)
Apis mellifera (1)
Helicobacter pylori (1)
Pseudomonas aeruginosa UCBPP-PA14 (1)
Ovis aries (1)
Oryza sativa Japonica Group (1)
Caenorhabditis elegans (1)
Plasmodium falciparum (1)
Burkholderia cenocepacia (1)
Saccharomyces cerevisiae (1)
Rattus norvegicus (1)
Drosophila melanogaster (1)
Haemophilus influenzae (1)
Moraxella catarrhalis (1)

Organisms

Homo sapiens (19)
Mus musculus (11)
lung metagenome (2)
Haemophilus influenzae (2)
human lung metagenome (2)
Moraxella catarrhalis (1)
Viruses (1)

Repository

biostudies-arrayexpress (97)
ENA (63)
geo (29)
EGA (6)
pride (6)
MassIVE (3)
MetaboLights (3)
GNPS (2)
dbGaP (1)
MetabolomicsWorkbench (1)

Tissue

Lung (2)
Breath (1)
Blood plasma (1)

Disease

Chronic obstructive pulmonary disease (2)
Critical chronic obstructive pulmonary disease (1)
Cystic fibrosis (1)
Cystic fibrosis (1)

Technology Type

Mass Spectrometry (7)
Mass spectrometry (2)
Shotgun proteomics (2)
NMR spectroscopy (1)
ESI (1)
Bottom-up proteomics (1)
Gel-based experiment (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Q Exactive (5)
Illumina NovaSeq 6000 (2)
Illumina Genome Analyzer (1)
Illumina HiSeq 3000 (1)
Illumina HiSeq 4000 (1)
NextSeq 500 (1)
Q Exactive Plus (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2015 (28)
2010 (15)
2013 (14)
2020 (11)
2021 (8)
2016 (8)
2022 (7)
2014 (7)
2012 (7)
2024 (5)
2011 (5)
2008 (5)
2025 (5)
2023 (5)
2009 (3)
2026 (3)
2005 (2)
2017 (1)
2019 (1)

CHEBI ID

CHEBI:70959 (3)
CHEBI:60645 (3)
CHEBI:15428 (3)
CHEBI:32816 (3)
CHEBI:17268 (3)
CHEBI:15760 (3)
CHEBI:70958 (3)
CHEBI:16737 (3)
CHEBI:7916 (3)
CHEBI:15724 (3)
CHEBI:16919 (3)
CHEBI:16344 (3)
CHEBI:18012 (3)
CHEBI:30769 (3)
CHEBI:16704 (3)
CHEBI:15891 (3)
CHEBI:37684 (2)
CHEBI:45441 (2)
CHEBI:91315 (2)
CHEBI:40521 (2)
CHEBI:35932 (2)
CHEBI:15366 (2)
CHEBI:27747 (2)
CHEBI:16244 (2)
CHEBI:20106 (2)
CHEBI:8087 (2)
CHEBI:85148 (2)
CHEBI:73770 (2)
CHEBI:43580 (2)
CHEBI:71179 (2)

Metabolite Name

Myoinositol (2)
Acetic acid (2)
Ureidosuccinic acid (2)
2-Hydroxy-3-methylbutyric acid (2)
Taurine (2)
L-Threonine (2)
N-acetylserine (2)
ADP (2)
Uridine (2)
Pantothenic acid (2)
Uridine 3'-monophosphate (1)
Sphingomyelin (d18:2/24:1, d18:1/24:2) (1)
Sphingomyelin (d18:2/16:0, d18:1/16:1) (1)
Myristoyl sulfate (1)
Dehydroisoandrosterone sulfate (1)
Cytidine 3'-monophosphate (1)
Anatabine (1)
2-hydroxyoleic acid (1)
13-methylmyristate (1)
Guanosine 2'-monophosphate (2'-GMP) (1)
Pimelate (heptanedioate) (1)
Oxidized glutathione (GSSG) (1)
Reduced glutathione (GSH) (1)
Isobar: fructose 1,6-diphosphate, glucose 1,6-diphosphate, myo-inositol 1,4 or 1,3-diphosphate (1)
Gamma-tocopherol|beta-tocopherol (1)
Vanillylmandelate (1)
Sphingomyelin (d18:1/15:0, d16:1/17:0) (1)
1-arachidonoyl-GPC (20:4n6) (1)
Glutarylcarnitine (C5) (1)
Glutarate (pentanedioate) (1)

First Public Date

2024 (10)
2025 (8)
2020 (7)
2023 (6)
2022 (5)
2021 (5)
2018 (5)
2026 (4)
2016 (4)
2015 (3)
2013 (3)
2014 (2)
2017 (1)

Classification

bacteria (3)
viruses (1)

Study type

Transcription profiling by array (46)
RNA-seq of coding RNA (16)
RNA-seq of non coding RNA (10)
Unknown experiment type (5)
Other (4)
Proteomic profiling by array (4)
ChIP-chip by tiling array (2)
Genotyping by array (2)
Comparative genomic hybridization by array (2)
Methylation profiling by array (2)
Animal - One-color microarray (1)
Cell line - High-throughput sequencing (1)
Transcription profiling by tiling array (1)
RNA-seq of total RNA (1)

Release Date

2025 (277)
2021 (267)
2022 (262)
2023 (240)
2024 (217)
2020 (217)
2019 (186)
2018 (174)
2016 (119)
2015 (117)
2017 (106)
2014 (84)
2013 (57)
2012 (45)
2011 (37)
2026 (32)
2010 (30)
2008 (17)
2009 (14)
2006 (8)
2005 (7)
2007 (7)
2004 (3)
2003 (1)
2001 (1)
2000 (1)

Lab affiliation

Centre de recherche Cardio-Thoracique de Bordeaux, INSERM U1045, PTIB, Hôpital Xavier Arnozan, Avenue du Haut Lévêque, 33604 Pessac Cedex (1)
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada (1)
Department Structure and Function of Proteins Helmholtz Centre for Infection Research Inhoffenstr. 7, 38124 Braunschweig, Germany (1)
Institute for Glycomics, Griffith University, Gold Coast, Queensland, 4215, Australia (1)
Moredun Proteomics Facility Moredun Research Institute (1)
Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Quebec, H3T 1E2, Canada Division of Experimental Medicine, McGill University, Montréal, Quebec H4A 3J1, Canada Gerald Bronfman Department of Oncology, McGill University, Montréal, Quebec H4A 3T2, Canada (1)

Previous page
1 / 265
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 265
Next page

Sort by:

Relevance

Page size

Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype

BACKGROUND: Chronic obstructive pulmonary disease (COPD) exacerbations significantly contribute to morbidity and mortality. The complex nature of COPD presents challenges in accurately predicting and understanding frequent exacerbations.

OBJECTIVE: This stu...

2024-02-23 | MTBLS9119 | MetaboLights

Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations in Adult and Pediatric Patients by Exhaled Breath Condensate Metabolomics.

Not available

ORGANISM(S): Homo sapiens

ST001164 | MetabolomicsWorkbench

Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics

Pulmonary exacerbations (PEx) are clinically impactful events for individuals with CF. Unfortunately, many CF individuals with PEx fail to regain their baseline lung function despite treatment. The objective of this study was to use unbiased proteomic technology (LC-MS/MS) to identify novel blood pr...

ORGANISM(S): Homo sapiens (Human)

2020-05-27 | PXD016089 | Pride